April 11, 2025 - 03:59

Recent discussions among financial experts highlight the growing concerns surrounding tariff uncertainties and their negative impact on tech stocks. Analysts emphasize that the volatility stemming from trade policies is causing significant fluctuations in the market, leading to a retreat in technology shares.
Nancy Tengler, from Laffer Tengler, shared insights on her investment strategies during this period of market weakness, indicating a cautious yet opportunistic approach to stock selection. Meanwhile, Jay Hatfield, CEO of Infrastructure Capital Advisors, expressed a more optimistic view of the U.S. economic landscape, suggesting that despite the ongoing trade challenges, there are still positive indicators for growth.
The conversation underscores the delicate balance investors must navigate as they respond to external pressures like tariffs while trying to capitalize on potential opportunities in the tech sector. As uncertainty looms, market participants are closely monitoring developments that could influence their investment decisions and the overall economic climate.
June 21, 2026 - 01:52
Mankind must not sacrifice human dignity at the altar of AISome ways of talking about human beings are always out of bounds. Sorting people by economic value into those who merit work and those who should be sidelined is one of them, and any society that...
June 20, 2026 - 18:23
Is Marvell Technology Going to $1 Trillion?Nvidia`s chief executive recently made a bold prediction about Marvell Technology, suggesting the chipmaker could one day join the trillion-dollar club. The comment sparked fresh interest in a...
June 19, 2026 - 18:29
A Tech Twist for Father's Day: New App Brings Old Photos to LifeForget the usual tie or toolbox this Father`s Day. A new mobile application is offering a different kind of gift: the chance to see faded memories with fresh eyes. The app uses simple artificial...
June 19, 2026 - 00:54
FDA panel backs first-of-its-kind flu vaccine using mRNA technologyA new kind of flu vaccine moved a step closer to the U.S. market Thursday. An advisory panel for the Food and Drug Administration voted overwhelmingly in favor of approving the first influenza shot...